BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March

Day

• 1
• 2
• 3
• 4
• 5
• 6

• Press Releases

  Anixa Biosciences to Host 2026 Annual Meeting of Stockholders and Provide Corporate Update Highlighting Recent Clinical and Regulatory Progress

  March 2, 2026

   · 

  4 min read
• Press Releases

  Quest Diagnostics Introduces AI Companion to Help Patients Understand and Act on Lab Test Results

  March 2, 2026

   · 

  4 min read
• Press Releases

  Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026

  March 2, 2026

   · 

  2 min read
• Press Releases

  KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Reduced Risk of Event-Free Survival Events by 47% and Risk of Death by 35% for Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer When Given Before and After Surgery

  March 2, 2026

   · 

  19 min read
• Press Releases

  PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

  March 2, 2026

   · 

  19 min read
• Press Releases

  ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025

  March 2, 2026

   · 

  20 min read
• Press Releases

  Celldex Presents Additional Positive Data from Phase 2 Chronic Spontaneous Urticaria (CSU) and Phase 2 Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Studies Further Demonstrating First-in-Class and Best-in-Disease Barzolvolimab Profile at AAAAI 2026

  March 2, 2026

   · 

  10 min read
• Press Releases

  Signatera™ MRD Data at ASCO GU Highlights Potential Utility Across GU Cancers, Including for Bladder Preservation

  March 2, 2026

   · 

  7 min read
• Press Releases

  Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization

  March 2, 2026

   · 

  5 min read
• Press Releases

  Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab - February 27, 2026

  March 2, 2026

   · 

  4 min read